Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Kei Sawara"'
Autor:
Akio Miyasaka, Yuichi Yoshida, Akihiko Murakami, Takao Hoshino, Kei Sawara, Hiroshi Numao, Yasuhiro Takikawa
Publikováno v:
Health Science Reports, Vol 5, Iss 1, Pp n/a-n/a (2022)
Abstract Background and aims To assess the efficacy and safety of treatment with glecaprevir/pibrentasvir in Japanese patients with genotype (GT) 1/2 hepatitis C virus (HCV) infection in a real‐world clinical setting. Methods A total of 230 patient
Externí odkaz:
https://doaj.org/article/963bdacd28ca4915b0021892d1765eb9
Publikováno v:
International Journal of General Medicine
Akio Miyasaka,1,2 Yuichi Yoshida,1,2 Akiko Suzuki,1 Kei Sawara,1,3 Yasuhiro Takikawa1 1Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Shiwa-gun, Iwate, Japan; 2Department of Gastroenterology, Iwa
Autor:
Kei Sawara, Takayoshi Oikawa, Tamami Abe, Yudai Fujiwara, Kei Endo, Hiroki Sato, Hidekatsu Kuorda, Okamoto Takuya, Yasuhiro Takikawa, Miki Yonezawa
Publikováno v:
World Journal of Gastroenterology
Background Lenvatinib is one of the first-line tyrosine kinase inhibitors used for unresectable hepatocellular carcinoma (HCC). In the present study, we evaluated the potential of early changes in the time-intensity curve (TIC) of arterial phase on
Publikováno v:
Journal of Gastroenterology and Hepatology. 34:1249-1255
BACKGROUND AND AIM L-carnitine (L-CA) has been used therapeutically to treat hepatic encephalopathy with hyperammonemia, but the mechanism by which L-CA contributes to ammonia detoxification in the brain is still unclear. Thus, the cytotoxicity and c
Autor:
Ken Ohuchi, Akihiko Murakami, Kei Sawara, Tadashi Kawakami, Yasuhiro Takikawa, Toshimi Yoshida, Yuichi Yoshida, Daisuke Watanabe, Takao Hoshino, Akio Miyasaka, Koichi Abe
Publikováno v:
Internal Medicine
Objective There are few reports on the outcomes of 12-week paritaprevir, ombitasvir, and ritonavir (PTV/OBV/r) treatment in real-world clinical settings. We aimed to evaluate the efficacy and safety of 12-week treatment with ritonavir-boosted paritap
Autor:
Hiroki Sato, Tamami Abe, Yudai Fujiwara, Kei Endo, Takayoshi Oikawa, Yohei Okada, Hidekatsu Kuroda, Yasuhiro Takikawa, Kei Sawara
Publikováno v:
Scandinavian journal of gastroenterology. 53(12)
Transcatheter arterial chemoembolization (TACE) is the standard therapy for patients with intermediate-stage hepatocellular carcinoma (HCC). This study aimed to determine whether combination therapy with radiofrequency ablation (RFA) and TACE was sup
Autor:
Takayoshi Oikawa, Hiroki Sato, Kei Endo, Yudai Fujiwara, Hidekatsu Kuroda, Yohei Kooka, Tamami Abe, Kei Sawara, Tomoaki Nagasawa, Yasuhiro Takikawa
Publikováno v:
Cancers
Volume 13
Issue 6
Cancers, Vol 13, Iss 1295, p 1295 (2021)
Volume 13
Issue 6
Cancers, Vol 13, Iss 1295, p 1295 (2021)
There is limited information regarding the oncological benefits of microwave ablation using ThermosphereTM technology for hepatocellular carcinoma. This study compared the overall survival and recurrence-free survival outcomes among patients with hep
Autor:
Takuro Sato, Jo Kanazawa, Hidekatsu Kuroda, Youhei Kooka, Takayoshi Oikawa, Yasuhiro Takikawa, Kei Endo, Kei Sawara, Tamami Abe, Hiroki Sato, Yudai Fujiwara
Publikováno v:
Cancers
Volume 12
Issue 8
Cancers, Vol 12, Iss 2146, p 2146 (2020)
Volume 12
Issue 8
Cancers, Vol 12, Iss 2146, p 2146 (2020)
Although sarcopenia is characterized by a loss of muscle strength and skeletal muscle mass, few studies have evaluated the effect of muscle strength on hepatocellular carcinoma (HCC) patients. We evaluated the impact of sarcopenia-related factors (gr
Autor:
Takayoshi Oikawa, K. Yusa, Hidekatu Kuroda, T. Satou, Kei Endo, Yasuhiro Takikawa, Okamoto Takuya, Kei Sawara, Miki Yonezawa, Tamami Abe
Publikováno v:
Annals of Oncology. 30:ix57
Background Lenvatinib is a new first-line molecular target drug for hepatocellular carcinoma (HCC) that is available worldwide. We evaluated the efficacy and safety of lenvatinib for unresectable HCC. Methods This study population included thirty-sev
Autor:
Keisuke Kakisaka, Tamotsu Sugai, Kei Endo, Kei Sawara, Hidekatsu Kuroda, Kazuyuki Ishida, Yasuhiro Takikawa, Takayoshi Oikawa
Publikováno v:
Internal Medicine
A 47-year-old Japanese man was referred to hospital after the detection of a liver tumor. Dynamic computed tomography and gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging were consistent wit